Pfizer and Novo Nordisk's fight for obesity drug developer Metsera ratcheted up on Tuesday as both companies submitted ...

Due to the litigation Pfizer filed Friday and Monday against Metsera, Novo Nordisk and the biotech’s lead shareholder, CEO ...

Shares of Hims & Hers Health ($HIMS) rallied on Tuesday after management said it’s in discussions with Novo Nordisk ($NVO) to ...

The bidding war for US obesity focused biotech Metsera, which has attracted offers from Pfizer and Novo Nordisk , and ...

NRGene Canada has signed its first commercial supply agreement for MaxBSFtm larvae, marking the company's transition from R&D to full-scale commercial operations in the Black Soldier Fly ...

The competition between Pfizer and Novo Nordisk over obesity drug developer Metsera escalated, with Novo's $10 billion offering deemed superior. Despite legal challenges from Pfizer, Novo continues to ...

One-third of commercial ATMPs with a European marketing authorisation withdraw from the market, limiting patient access ...

The past few months have been pivotal for Pfizer Inc. We are really excited about our future and confident that we are in a ...

Taking a closer look at the numbers, Comirnaty sales slipped 19% globally to $1.15 billion, the Prevnar franchise experienced a 3% global sales decline to $1.7 billion, and Abrysvo’s performance ...

FIZE Medical, a leader in smart fluid management solutions for critically ill patients, announced today an investment and distribution partnership with Eldan, a member of Neopharm Group. Under the ...

Gold Spot US Dollar, Pfizer Inc, US Dollar Index Futures, S&P 500 Futures. Read 's Market Analysis on Investing.com ...

C21Marketplace hosts a monthly ‘Hot Properties’ screenings event on the platform to help connect programme suppliers and ...